Epipolymorphisms associated with the clinical outcome of autoimmune arthritis affect CD4+ T cell activation pathways.

MLA

Spreafico, Roberto, et al. “Epipolymorphisms Associated with the Clinical Outcome of Autoimmune Arthritis Affect CD4+ T Cell Activation Pathways.” Proceedings of the National Academy of Sciences of the United States of America, vol. 113, no. 48, Nov. 2016, pp. 13845–50. EBSCOhost, https://doi.org/10.1073/pnas.1524056113.

APA

Spreafico, R., Rossetti, M., Whitaker, J. W., Wang, W., Lovell, D. J., & Albani, S. (2016). Epipolymorphisms associated with the clinical outcome of autoimmune arthritis affect CD4+ T cell activation pathways. Proceedings of the National Academy of Sciences of the United States of America, 113(48), 13845–13850. https://doi.org/10.1073/pnas.1524056113

Chicago

Spreafico, Roberto, Maura Rossetti, John W Whitaker, Wei Wang, Daniel J Lovell, and Salvatore Albani. 2016. “Epipolymorphisms Associated with the Clinical Outcome of Autoimmune Arthritis Affect CD4+ T Cell Activation Pathways.” Proceedings of the National Academy of Sciences of the United States of America 113 (48): 13845–50. doi:10.1073/pnas.1524056113.